Cholemic Nephropathy: Hyperbilirubinemia and its Impact on Renal Function
Abstract
Cholemic nephropathy represents a spectrum of renal injury, from proximal tubulopathy to intrarenal bile cast formation, found in patients with severe liver dysfunction. It is caused by hyperbilirubinemia, usually in jaundiced patients. Acute kidney injury is one of the most important complications in patients with end-stage liver disease. The relationship between liver disease and renal impairment, especially the effect of hyperbilirubinemia on renal tissue and renal function, has not been fully elucidated. These considerations deem necessary for nephrologists, when performing a clinical evaluation of patients with liver diseases, for the implementation of an integrated medical approach. This review focuses on the current knowledge on cholemic nephropathy with emphasis on the role of hyperbilirubinemia on renal impairment. The treatment strategies and outcome are also discussed.
Keywords
How to Cite
References
Krones E, Pollheimer MJ, Rosenkranz AR, Fickert P. Cholemic nephropathy—Historical notes and novel perspectives. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4 Pt B):1356–66. http://dx.doi.org/10.1016/j.bbadis.2017.08.028
Hecher R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure. Lancet 1956;2:1121–5. http://dx.doi.org/10.1016/S0140-6736(56)90149-0
Schroeder ET, Shear L, Sancetta SM, Gabuzda GJ. Renal failure in patients with cirrhosis of the liver. 3. Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin. Am J Med. 1967;43(6):887–96. http://dx.doi.org/10.1016/0002-9343(67)90247-1
Aniort J, Poyet A, Kemeny JL, Philipponnet C, Heng AE. Bile cast nephropathy caused by obstructive cholestasis. Am J Kidney Dis. 2017;69(1):143–6. http://dx.doi.org/10.1053/j.ajkd.2016.08.023
Gonwa TA, Wadei HM. Kidney disease in the setting of liver failure: Core curriculum 2013. Am J Kidney Dis. 2013;62(6):1198–212. http://dx.doi.org/10.1053/j.ajkd.2013.07.017
Kalakonda, A. John, S. Physiology: Bilirubin. Treasure Island, FL: StatPearls Publishing; 2018.
Memon N, Weinberger BI, Hegyi T, Aleksunes LM. Inherited disorders of bilirubin Clearance. Pediatr Res. 2016;79(3):378–86. http://dx.doi.org/10.1038/pr.2015.247
Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. 2004;69(2):299–304.
Sticova E, Jirsa M. New insights in bilirubin metabolism and their clinical implications. World J Gastroenterol. 2013;19(38):6398–407.http://dx.doi.org/10.3748/wjg.v19.i38.6398
Angeli P, Merkel C. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. J Hepatol. 2008;48:S93–103. http://dx.doi.org/10.1016/j.jhep.2008.01.010
Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis. Hepatology. 1994;20(6):1495–501. http://dx.doi.org/10.1002/hep.1840200619
Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C, Nguyen-Khac E, et al. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology. 2007;46(6):1872–82. http://dx.doi.org/10.1002/hep.21920
Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E, et al. Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features. Hepatology. 2007;45(1):223–9. http://dx.doi.org/10.1002/hep.21443
Montoliu S, Ballesté B, Planas R, Alvarez MA, Rivera M, Miquel M, et al. Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites. Clin Gastroenterol Hepatol. 2010;8(7):616–22. http://dx.doi.org/10.1016/j.cgh.2010.03.029
Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361:1279–90. http://dx.doi.org/10.1056/NEJMra0809139
Martín-Llahí M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2011;140(2):488–96. http://dx.doi.org/10.1053/j.gastro.2010.07.043
Angeli P, Ginès P, Wong F, Bernardi M, Boyer TD, Gerbes A, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62(4):968–74. http://dx.doi.org/10.1016/j.jhep.2014.12.029
Spencer K. Analytical reviews in clinical biochemistry: The estimation of creatinine. Ann Clin Biochem 1986;23(Pt. 1):1–25. http://dx.doi.org/10.1177/000456328602300101
Watkins RE, Felkamp CS, Thibert RJ, Zak B. Interesting interferences in a direct serum creatinine reaction. Microchem J. 1976;21(4):370–84. http://dx.doi.org/10.1016/0026-265X(76)90056-4
Poge U, Gerhardt T, Stoffel-Wagner B, Klehr HU, Sauerbruch T, Woitas RP. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant. 2006;21(3):660–4. http://dx.doi.org/10.1093/ndt/gfi305
van Slambrouck CM, Salem F, Meehan SM, Chang A. Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction. Kidney Int. 2013;84(1):192–7. http://dx.doi.org/10.1038/ki.2013.78
Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL et al. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Supplements. 2012;1;2(1):1–138.
Fede G, D’Amico G, Arvaniti V, Tsochatzis E, Germani G, Georgiadis D, et al. Renal failure and cirrhosis: A systematic review of mortality and prognosis. J Hepatol. 2012;56(4):810–18. http://dx.doi.org/10.1016/j.jhep.2011.10.016
Fagundes C, Barreto R, Guevara M, Garcia E, Solà E, Rodríguez E, et al. A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J Hepatol. 2013;59(3):474–81. http://dx.doi.org/10.1016/j.jhep.2013.04.036
Sens F, Bacchetta J, Rabeyrin M, Julliard L. Efficacy of extracorporeal albumin dialysis for acute kidney injury due to cholestatic jaundice nephrotoxicity. BMJ Case Rep. 2016;2016:1–5. http://dx.doi.org/10.1038/ki.1990.296
Sitprija V, Kashemsant U, Sriratanaban A, Arthachinta S, Poshyachinda V. Renal function in obstructive jaundice in man: Cholangiocarcinoma mode. Kidney Int. 1990;38(5):948–55. http://dx.doi.org/10.1038/ki.1990.296
Mohapatra MK, Behera AK, Karua PC, Bariha PK, Rath A, Aggrawal KC, et al. Urinary bile casts in bile cast nephropathy secondary to severe falciparum malaria. Clin Kidney J. 2016;9(4):644–8. http://dx.doi.org/10.1093/ckj/sfw042
Betjes M, Bajema I. The pathology of jaundice-related renal insufficiency: Cholemic nephrosis revisited. J Nephrol. 2006;19(2):229–33.
Martínez-Cecilia. D, Reyes-Díaz M, Ruiz-Rabelo J, Gomez-Alvarez M, Villanueva CM, Álamo J, et al. Oxidative stress influence on renal dysfunction in patients with obstructive jaundice: A case and control prospective study. Redox Biol. 2016;8:160–4. http://dx.doi.org/10.1016/j.redox.2015.12.009
Fickert P, Krones E, Pollheimer MJ, Thueringer A, Moustafa T, Silbert D, et al. Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice. Hepatology. 2013;58(6):2056–69. http://dx.doi.org/10.1002/hep.26599
Odell GB, Bolen JL, Poland RL, Seungdambong S, Cukier JO. Protection from bilirubin nephropathy in jaundiced Gunn rats. Gastroenterology. 1974;66(6):1218–24.
Bairaktari E, Liamis G, Tsolas O, Elisaf M. Partially reversible renal tubular damage in patients with obstructive jaundice. Hepatology. 2001;33(6):1365–9. http://dx.doi.org/10.1053/jhep.2001.25089
Holmes TW Jr. The histologic lesion of cholemic nephrosis. J Urol. 1953;70(5):677–85. http://dx.doi.org/10.1016/S0022-5347(17)67968-0
Jain K, Gupta A, Singh HK, Nickeleit V, Kshirsagar AV. Bile cast nephropathy. Kidney Int. 2015;87(2):484. http://dx.doi.org/10.1038/ki.2014.233
Elsom KA. Renal function in obstructive jaundice. Arch Intern Med (Chic). 1937;60 (6):1028–33. http://dx.doi.org/10.1001/archinte.1937.00180060081008
Thompson LL, Frazier WD, Ravdin LS. The renal lesion in obstructive jaundice. Am J Med Sci. 1940;199:305–12. http://dx.doi.org/10.1097/00000441-194003000-00001
Licata A, Maida M, Bonaccorso A, Macaluso FS, Cappello M, Craxì A, et al. Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study. World J Hepatol. 2013;27;5(12):685–91.
Nazar A, Pereira GH, Guevara M, Martín-Llahi M, Pepin MN, Marinelli M, et al. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology. 2010;51(1):219–26. http://dx.doi.org/10.1002/hep.23283
de Vries E, Beuers U. Management of cholestatic disease in 2017. Liver Int. 2017;37(Suppl. 1):123–9. http://dx.doi.org/10.1111/liv.13306
Moustafa T, Fickert P, Magnes C, Guelly C, Thueringer A, Frank S, et al. Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury. Gastroenterology. 2012;142(1):140–51. http://dx.doi.org/10.1053/j.gastro.2011.09.051
Krones E, Eller K, Pollheimer MJ, Racedo S, Kirsch AH, Frauscher B, et al. Nor Ursodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice. J Hepatol. 2017;67(1):110–19. http://dx.doi.org/10.1016/j.jhep.2017.02.019
Copyright and licence
Copyright (c) 2019 Jonathan Chávez-Iñiguez, Alejandra Meza-Ríos, Arturo Santos-Garcia, Guillermo García-García, Juan Armendáriz-Borunda

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

